Authors:
Johansson, LO
Bjornerud, A
Ahlstrom, HK
Ladd, DL
Fujii, DK
Citation: Lo. Johansson et al., A targeted contrast agent for magnetic resonance imaging of thrombus: Implications of spatial resolution, J MAGN R I, 13(4), 2001, pp. 615-618
Citation: A. Bjornerud et al., Pre-clinical results with Clariscan (TM) (NC100150 Injection); experience from different disease models, MAGN RES MA, 12(2-3), 2001, pp. 99-103
Authors:
Lokling, KE
Fossheim, SL
Skurtveit, R
Bjornerud, A
Klaveness, J
Citation: Ke. Lokling et al., pH-sensitive paramagnetic liposomes as MRI contrast agents: in vitro feasibility studies, MAGN RES IM, 19(5), 2001, pp. 731-738
Authors:
Fossheim, SL
Il'yasov, KA
Hennig, J
Bjornerud, A
Citation: Sl. Fossheim et al., Thermosensitive paramagnetic liposomes for temperature control during MR imaging-guided hyperthermia: In vitro feasibility studies, ACAD RADIOL, 7(12), 2000, pp. 1107-1115
Authors:
Kellar, KE
Fujii, DK
Gunther, WHH
Briley-Saebo, K
Bjornerud, A
Spiller, M
Koenig, SH
Citation: Ke. Kellar et al., NC100150 injection, a preparation of optimized iron oxide nanoparticles for positive-contrast MR angiography, J MAGN R I, 11(5), 2000, pp. 488-494
Authors:
Bjornerud, A
Briley-Saebo, K
Johansson, LO
Kellar, KE
Citation: A. Bjornerud et al., Effect of NC100150 injection on the H-1 NMR linewidth of human whole bloodex vivo: Dependency on blood oxygen tension, MAGN RES M, 44(5), 2000, pp. 803-807
Authors:
Simonsen, CZ
Ostergaard, L
Vestergaard-Poulsen, P
Rohl, L
Bjornerud, A
Gyldensted, C
Citation: Cz. Simonsen et al., CBF and CBV measurements by USPIO bolus tracking: Reproducibility and comparison with Gd-based values, J MAGN R I, 9(2), 1999, pp. 342-347
Authors:
Rohl, L
Ostergaard, L
Simonsen, CZ
Vestergaard-Poulsen, P
Sorensen, L
Bjornerud, A
Saebo, KB
Gyldensted, C
Citation: L. Rohl et al., NC100150-enhanced 3D-SPGR MR angiography of the common carotid artery in apig vascular stenosis model - Quantification of stenosis and dose optimization, ACT RADIOL, 40(3), 1999, pp. 282-290